Research Papers:
6Shogaol attenuates LPSinduced inflammation in BV2 microglia cells by activating PPARγ
PDF | Full Text | How to cite
Metrics: PDF 5522 views | Full Text 7157 views
Qinghe Han2, Qinghai Yuan2 and Guanghong Xie1
1College of Veterinary Medicine, Jilin University, Changchun 130062, China
2The Second Hospital of Jilin University, Changchun 130000, China
Correspondence to:
Guanghong Xie, email: [email protected]
Keywords: 6-Shogaol, LPS, PPAR-γ, BV2 microglia
Received: November 08, 2016 Accepted: March 01, 2017 Published: March 30, 2017
ABSTRACT
6-Shogaol, a pungent agent isolated from Zingiber officinale Roscoe, has been known to have anti-tumor and anti-inflammatory effects. However, the anti-inflammatory effects and biological mechanism of 6-Shogaol in LPS-activated BV2 microglia remains largely unknown. In this study, we evaluated the anti-inflammatory effects of 6-Shogaol in LPS-activated BV2 microglia. 6-Shogaol was administrated 1 h before LPS treatment. The production of inflammatory mediators were detected by ELISA. The expression of NF-κB and PPAR-γ were detected by western blot analysis. Our results revealed that 6-Shogaol inhibited LPS-induced TNF-α, IL-1β, IL-6, and PGE2 production in a concentration dependent manner. Furthermore, 6-Shogaol inhibited LPS-induced NF-κB activation by inhibiting phosphorylation and nuclear translocation of NF-κB p65. In addition, 6-Shogaol could increase the expression of PPAR-γ. Moreover, inhibition of PPAR-γ by GW9662 could prevent the inhibition of 6-Shogaol on LPS-induced inflammatory mediator production. In conclusion, 6-Shogaol inhibits LPS-induced inflammation by activating PPAR-γ.